Company
Board Member, CEO
2024-01-01–present
1 appearance
Latest appearance 2026-02-26
Richard J. Daly
Board Member
CEO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard J. Daly
The company reported in an 8-K filed July 16, 2026 that Richard J. Daly resigned as director, effective July 15, 2026. The company reported in an 8-K filed July 8, 2026 that Richard J. Daly resigned as member of the board of directors of the Company and any committee thereof. The company reported in an 8-K filed May 23, 2025 that Richard J. Daly was appointed Director, effective May 20, 2025. Equibles holds 7 filed executive changes naming Richard J. Daly; each is listed under recent activity with its source filing. Richard J. Daly has spoken on 1 earnings call across 1 company, most recently on February 26, 2026.
“as of the Effective Time, each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.”
“each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2025-05-20–present
-
Organization not stated
CEO
Proxy statement
Current2024-01-01–present
-
Organization not stated
Board Member
Proxy statement
2025-05-20–2026-07-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: director
-
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
-
Executive change Appointed: Director
-
Executive change Appointed: Director
-
Executive change Appointed: Chief Executive Officer
-
Executive change Appointed: Board of Directors
-
Executive change Appointed: Director